EUVIMEDEUVIMED entdecken
Crossref

JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms

Michał Łączak, Martyna Kuczyńska, Joanna Grygier, Dominika Andrzejewska, Wiktoria Grochowska, Hanna Gulaczyk, Krzysztof Lewandowski

Hematology in Clinical Practice · 2022

DOI: 10.5603/hcp.a2021.0013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2022. Verfasst von Michał Łączak und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lympho- and myeloproliferative neoplasms are a very heterogeneous group of haematological malignancies originating from a haematopoietic stem cell (HSC). In most of them, the neoplastic transformation is a result of the acquisition of molecular defects by HSC or progenitor cells, impairing their proliferation, differentiation and maturation. Herein, the role of the Janus kinase-signal transduction and transcription activation (JAK-STAT) signalling pathway in the normal and neoplastic lympho- and myelopoiesis is presented. Particular attention is paid to the molecular aberrations of the JAK and STAT genes and their impact on JAK and STAT signalling pathway function and the mutation-driven mechanism of the lymphoid and myeloid cells neoplastic transformation. In the Authors’ opinion, its early identification allows to incorporate the molecularly targeted drugs, including JAK-STAT pathway signalling inhibitors, to the therapeutic algorithm used and to improve the treatment results of lymphoid- and myeloid neoplasms.

Zitieren

APA

Łączak, M., Kuczyńska, M., Grygier, J., Andrzejewska, D., Grochowska, W., Gulaczyk, H., & Lewandowski, K. (2022). JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.a2021.0013

Vancouver

Łączak M, Kuczyńska M, Grygier J, Andrzejewska D, Grochowska W, Gulaczyk H, et al. JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms. Hematology in Clinical Practice. 2022. doi:10.5603/hcp.a2021.0013

BibTeX
@article{czak2022,
  author = {Łączak, Michał and Kuczyńska, Martyna and Grygier, Joanna and Andrzejewska, Dominika and Grochowska, Wiktoria and Gulaczyk, Hanna and Lewandowski, Krzysztof},
  title = {JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms},
  journal = {Hematology in Clinical Practice},
  year = {2022},
  doi = {10.5603/hcp.a2021.0013}
}
Kostenlos starten →